We are live on ! Find out more
First Manhattan

First Manhattan Portfolio holdings

AUM $36.1B
1-Year Est. Return 11.5%
This Fund
S&P 500
This Quarter Est. Return
+4.14%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$34.3B
AUM Growth
+$184M
Cap. Flow
-$333M
Cap. Flow %
-0.97%
Top 10 Hldgs %
59.6%
Holding
718
New
38
Increased
168
Reduced
304
Closed
40

Top Buys

Rank Stock Value
1
ASML icon
ASML
ASML
+$195M
2
KNSL icon
Kinsale Capital Group
KNSL
+$72.3M
3
GEV icon
GE Vernova
GEV
+$67.8M
4
VRT icon
Vertiv
VRT
+$55.5M
5
AMAT icon
Applied Materials
AMAT
+$37.8M

Sector Composition

Rank Sector Weight
1 Financials 48.05%
2 Technology 18.6%
3 Consumer Discretionary 7.51%
4 Healthcare 6.13%
5 Communication Services 5.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WNEB icon
651
Western New England Bancorp
WNEB
$287M
$144K ﹤0.01%
15,518
ROIV icon
652
Roivant Sciences
ROIV
$25.2B
$122K ﹤0.01%
12,100
NCA icon
653
Nuveen California Municipal Value Fund
NCA
$299M
$118K ﹤0.01%
+13,621
New +$117K
NRK icon
654
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$900M
$104K ﹤0.01%
+10,010
New +$105K
EEX
655
DELISTED
Emerald Holding
EEX
$99.6K ﹤0.01%
25,338
KLTR icon
656
Kaltura
KLTR
$211M
$94K ﹤0.01%
50,000
EVLV icon
657
Evolv Technologies
EVLV
$943M
$88.8K ﹤0.01%
28,465
-31,069
-52% -$109K
VLN icon
658
Valens Semiconductor
VLN
$176M
$88.7K ﹤0.01%
43,458
OPK icon
659
Opko Health
OPK
$921M
$85.9K ﹤0.01%
51,750
PTEN icon
660
Patterson-UTI
PTEN
$3.87B
$85.8K ﹤0.01%
+10,441
New +$87.6K
ACP
661
abrdn Income Credit Strategies Fund
ACP
$640M
$80.8K ﹤0.01%
+13,712
New +$82.7K
CERS icon
662
Cerus
CERS
$587M
$79.2K ﹤0.01%
57,000
CHW
663
Calamos Global Dynamic Income Fund
CHW
$544M
$67.2K ﹤0.01%
+10,522
New +$71.4K
IMRX icon
664
Immuneering
IMRX
$279M
$49.1K ﹤0.01%
32,325
ABUS icon
665
Arbutus Biopharma
ABUS
$865M
$48.9K ﹤0.01%
14,000
ZVIA icon
666
Zevia
ZVIA
$108M
$47.5K ﹤0.01%
+22,000
New +$72K
NRO
667
Neuberger Real Estate Securities Income Fund Inc
NRO
$194M
$46.5K ﹤0.01%
+14,081
New +$47.1K
TSHA icon
668
Taysha Gene Therapies
TSHA
$1.59B
$39.6K ﹤0.01%
28,500
CALC icon
669
CalciMedica
CALC
$12M
$25.3K ﹤0.01%
+13,226
New +$33K
ORIO
670
Orion Digital Corp
ORIO
$15.4M
$22.4K ﹤0.01%
26,400
LUCD icon
671
Lucid Diagnostics
LUCD
$173M
$18.8K ﹤0.01%
12,600
PDSB icon
672
PDS Biotechnology
PDSB
$38.1M
$17.9K ﹤0.01%
+15,000
New +$21.3K
GROV icon
673
Grove Collaborative
GROV
$45M
$15.7K ﹤0.01%
11,662
OVID icon
674
Ovid Therapeutics
OVID
$435M
$8.11K ﹤0.01%
26,000
ALSN icon
675
Allison Transmission
ALSN
$10.1B
-10,322
Closed -$1.12M

Similar funds

First Manhattan's Q1 2025 Portfolio in Review

As of Q1 2025, First Manhattan held 718 positions worth $34.3B, up 0.54% from $34.1B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

First Manhattan's Q1 2025 filing shows 38 new, 168 increased, 304 reduced and 40 closed positions. Its largest new stake was Centene: 474,879 shares worth $28.8M. The largest sale was Berkshire Hathaway Class A, an estimated $400M.

By sector, the portfolio is most concentrated in Financials at 48% of assets, up from 45% a quarter earlier, followed by Technology and Consumer Discretionary.

  • First Manhattan's largest Q1 2025 buy was Centene: 474,879 shares worth $28.8M.
  • First Manhattan added most to ASML in Q1 2025, an estimated $195M increase.
  • First Manhattan's biggest Q1 2025 reduction was Berkshire Hathaway Class A, cutting an estimated $400M.
  • First Manhattan fully exited Aspen Technology Inc in Q1 2025, selling an estimated $170M.
  • First Manhattan's ten largest holdings make up 60% of its $34.3B portfolio in Q1 2025.
  • First Manhattan opened 38 new positions and closed 40 in Q1 2025.
  • First Manhattan's portfolio value rose 0.54% quarter-over-quarter to $34.3B.

Based on First Manhattan's 13F filing for Q1 2025, filed 15 May 2025.